United States Biotechnology & Medical Research

Longeveron Inc (LGVN)

Track

Track

Longeveron Inc. experienced multiple divestments by insiders during May 2025. Key figures, including Rock Soffer and Joshua Hare, executed various sales of equity. The most recent trading activity occurred on May 30, 2025. No significant insider transactions have been recorded within the last three months.
Ticker: LGVN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Longeveron Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Soffer Rock Non-Executive Director
Transaction date
Sale
Price
170.49
Quantity 75,838 -4.8%
Value US$4,020,803
3.2
Soffer Rock Non-Executive Director
Transaction date
Sale
Price
25.91
Quantity 36,369 +19.3%
Value US$723,908
3.2
Rock Soffer Director Non-Executive Director
Transaction date
Proposed sale
Price
125.91
Quantity 749
Value US$3,788,865
3.2
Soffer Rock Non-Executive Director
Transaction date
Sale
Price
1.32
Quantity 2,000 -0.9%
Value US$2,640
1.7
Hare Joshua Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
1.40
Quantity 5,250 -0.7%
Value US$7,367
1.7
Hare Joshua Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.38
Quantity 5,250
Value US$7,220
2.2
Baluch Khoso Non-Executive Director
Transaction date
Sale
Price
2.07
Quantity 1,250 -5.0%
Value US$2,588
2.2
Baluch Khoso Director Non-Executive Director
Transaction date
Proposed sale
Price
2.06
Quantity 1,250
Value US$2,575
1.7
Hare Joshua Chief Scientific Officer Executive Director Large shareholder
Transaction date
Purchase
Price
2.35
Quantity 42,553 +7.2%
Value US$100,000
2.2
Hashad Mohamed Wa'el Ahmed Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.35
Quantity 10,638 +118.5%
Value US$24,999
3.2
Soffer Rock Non-Executive Director
Transaction date
Purchase
Price
2.35
Quantity 31,915 +18.1%
Value US$75,000
1.7
Hare Joshua Chief Scientific Officer Executive Director Large shareholder
Transaction date
Purchase
Price
2.35
Quantity 106,383 +22.0%
Value US$250,000
3.2
Soffer Rock Non-Executive Director
Transaction date
Purchase
Price
2.35
Quantity 106,383 +151.5%
Value US$250,000
0.5
Ross Cathy Non-Executive Director
Transaction date
Purchase
Price
1.31
Quantity 5,000 +100.0%
Value US$6,544
2.2
Baluch Khoso Non-Executive Director
Transaction date
Purchase
Price
1.43
Quantity 8,322 +124.6%
Value US$11,915
2.2
Baluch Khoso Non-Executive Director
Transaction date
Purchase
Price
1.40
Quantity 1,678 +33.6%
Value US$2,342
0.5
PFEFFER JEFFREY Non-Executive Director
Transaction date
Purchase
Price
1.35
Quantity 10,000 +200.0%
Value US$13,500
3.6
Clavijo James CFO and Treasurer Officer
Transaction date
Sale
Price
3.51
Quantity 5,000 -9.6%
Value US$17,550
3.6
Clavijo James CFO and Treasurer Officer
Transaction date
Sale
Price
3.43
Quantity 10,000 -16.1%
Value US$34,300
3.6
Clavijo James CFO and Treasurer Officer
Transaction date
Sale
Price
3.48
Quantity 8,532 -12.0%
Value US$29,691
1.7
Hare Joshua Chief Scientific Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
4.28
Quantity 20,000 -0.3%
Value US$85,600
1.7
Hare Joshua Chief Scientific Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
3.74
Quantity 20,000 -0.3%
Value US$74,800
1.7
Hare Joshua Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
3.61
Quantity 100,000 -1.3%
Value US$361,000
3.6
Clavijo James CFO and Treasurer Officer
Transaction date
Sale
Price
8.26
Quantity 36,955 -31.7%
Value US$305,248
3.2
Soffer Rock Non-Executive Director
Transaction date
Sale
Price
7.50
Quantity 4,000 -0.6%
Value US$30,000
3.2
Soffer Rock Non-Executive Director
Transaction date
Sale
Price
7.78
Quantity 8,000 -1.2%
Value US$62,200
3.2
Soffer Rock Non-Executive Director
Transaction date
Sale
Price
8.06
Quantity 7,500 -1.1%
Value US$60,435
1.7
Hare Joshua Chief Scientific Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
10.00
Quantity 78 -0.0%
Value US$780
1.7
Hare Joshua Chief Scientific Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
10.00
Quantity 19,922 -0.3%
Value US$199,290
2.5
Green Geoff CEO Officer
Transaction date
Purchase
Price
3.81
Quantity 1,000 +0.7%
Value US$3,810
3.2
Soffer Rock Non-Executive Director
Transaction date
Purchase
Price
3.76
Quantity 12,000 +30.2%
Value US$45,120
1.7
Hare Joshua Chief Scientific Officer Executive Director Large shareholder
Transaction date
Purchase
Price
3.69
Quantity 2,500 +0.0%
Value US$9,225
3.2
Soffer Rock Non-Executive Director
Transaction date
Purchase
Price
3.57
Quantity 4,000 +11.2%
Value US$14,280
3.2
Soffer Rock Non-Executive Director
Transaction date
Purchase
Price
3.45
Quantity 3,900 +12.2%
Value US$13,455
1.7
Hare Joshua Chief Scientific Officer Executive Director Large shareholder
Transaction date
Purchase
Price
3.39
Quantity 3,015 +0.0%
Value US$10,221
1.7
Hare Joshua Chief Scientific Officer Executive Director Large shareholder
Transaction date
Purchase
Price
3.38
Quantity 1,985 +0.0%
Value US$6,709
3.3
Lehr Paul T General Counsel, Secretary Officer
Transaction date
Purchase
Price
3.34
Quantity 1,750 +1.5%
Value US$5,845
3.6
Clavijo James CFO and Treasurer Officer
Transaction date
Purchase
Price
3.34
Quantity 5,000 +6.7%
Value US$16,700
0.5
Soffer Donald M Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 100,000 +186.9%
Value US$1,000,000
3.2
Soffer Rock Non-Executive Director
Transaction date
Purchase
Price
8.05
Quantity 100 +0.4%
Value US$805
1.7
Hare Joshua Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
8.23
Quantity 1,000 +0.0%
Value US$8,230
1.7
Hare Joshua Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
10.00
Quantity 102,000 +1.3%
Value US$1,020,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-02 2025-05-30 S Sale
3.2
Soffer Rock
Non-Executive Director
75,838 -4.8%
170.49
US$4,020,803 		75,838 -4.8% 170.49 US$4,020,803
2025-06-02 2025-05-29 S Sale
3.2
Soffer Rock
Non-Executive Director
36,369 +19.3%
25.91
US$723,908 		36,369 +19.3% 25.91 US$723,908
2025-05-29 2025-05-29 PrS Proposed sale
3.2
Rock Soffer

Director

Non-Executive Director
749
125.91
US$3,788,865 		749 125.91 US$3,788,865
2025-05-27 2025-05-22 S Sale
3.2
Soffer Rock
Non-Executive Director
2,000 -0.9%
1.32
US$2,640 		2,000 -0.9% 1.32 US$2,640
2025-05-16 2025-05-16 S Sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
5,250 -0.7%
1.40
US$7,367 		5,250 -0.7% 1.40 US$7,367
2025-05-15 2025-05-15 PrS Proposed sale
1.7
Hare Joshua

Officer; Director

Executive Director
5,250
1.38
US$7,220 		5,250 1.38 US$7,220
2024-12-04 2024-12-02 S Sale
2.2
Baluch Khoso
Non-Executive Director
1,250 -5.0%
2.07
US$2,588 		1,250 -5.0% 2.07 US$2,588
2024-11-27 2024-11-27 PrS Proposed sale
2.2
Baluch Khoso

Director

Non-Executive Director
1,250
2.06
US$2,575 		1,250 2.06 US$2,575
2024-04-12 2024-04-11 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
42,553 +7.2%
2.35
US$100,000 		42,553 +7.2% 2.35 US$100,000
2024-04-12 2024-04-11 B Purchase
2.2
Hashad Mohamed Wa'el Ahmed

Chief Executive Officer

Executive Director
10,638 +118.5%
2.35
US$24,999 		10,638 +118.5% 2.35 US$24,999
2024-04-12 2024-04-11 B Purchase
3.2
Soffer Rock
Non-Executive Director
31,915 +18.1%
2.35
US$75,000 		31,915 +18.1% 2.35 US$75,000
2024-04-12 2024-04-10 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
106,383 +22.0%
2.35
US$250,000 		106,383 +22.0% 2.35 US$250,000
2024-04-12 2024-04-10 B Purchase
3.2
Soffer Rock
Non-Executive Director
106,383 +151.5%
2.35
US$250,000 		106,383 +151.5% 2.35 US$250,000
2024-01-11 2024-01-10 B Purchase
0.5
Ross Cathy
Non-Executive Director
5,000 +100.0%
1.31
US$6,544 		5,000 +100.0% 1.31 US$6,544
2024-01-02 2023-12-29 B Purchase
2.2
Baluch Khoso
Non-Executive Director
8,322 +124.6%
1.43
US$11,915 		8,322 +124.6% 1.43 US$11,915
2024-01-02 2023-12-28 B Purchase
2.2
Baluch Khoso
Non-Executive Director
1,678 +33.6%
1.40
US$2,342 		1,678 +33.6% 1.40 US$2,342
2023-12-29 2023-12-28 B Purchase
0.5
PFEFFER JEFFREY
Non-Executive Director
10,000 +200.0%
1.35
US$13,500 		10,000 +200.0% 1.35 US$13,500
2023-06-29 2023-06-29 S Sale
3.6
Clavijo James

CFO and Treasurer

Officer
5,000 -9.6%
3.51
US$17,550 		5,000 -9.6% 3.51 US$17,550
2023-06-29 2023-06-28 S Sale
3.6
Clavijo James

CFO and Treasurer

Officer
10,000 -16.1%
3.43
US$34,300 		10,000 -16.1% 3.43 US$34,300
2023-06-29 2023-06-27 S Sale
3.6
Clavijo James

CFO and Treasurer

Officer
8,532 -12.0%
3.48
US$29,691 		8,532 -12.0% 3.48 US$29,691
2023-01-30 2023-01-27 PlS Planned sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
20,000 -0.3%
4.28
US$85,600 		20,000 -0.3% 4.28 US$85,600
2022-12-05 2022-12-02 PlS Planned sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
20,000 -0.3%
3.74
US$74,800 		20,000 -0.3% 3.74 US$74,800
2022-10-18 2022-10-12 S Sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
100,000 -1.3%
3.61
US$361,000 		100,000 -1.3% 3.61 US$361,000
2022-06-07 2022-06-03 S Sale
3.6
Clavijo James

CFO and Treasurer

Officer
36,955 -31.7%
8.26
US$305,248 		36,955 -31.7% 8.26 US$305,248
2022-05-24 2022-05-24 S Sale
3.2
Soffer Rock
Non-Executive Director
4,000 -0.6%
7.50
US$30,000 		4,000 -0.6% 7.50 US$30,000
2022-05-24 2022-05-23 S Sale
3.2
Soffer Rock
Non-Executive Director
8,000 -1.2%
7.78
US$62,200 		8,000 -1.2% 7.78 US$62,200
2022-05-24 2022-05-20 S Sale
3.2
Soffer Rock
Non-Executive Director
7,500 -1.1%
8.06
US$60,435 		7,500 -1.1% 8.06 US$60,435
2022-04-20 2022-04-19 PlS Planned sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
78 -0.0%
10.00
US$780 		78 -0.0% 10.00 US$780
2022-04-20 2022-04-18 PlS Planned sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
19,922 -0.3%
10.00
US$199,290 		19,922 -0.3% 10.00 US$199,290
2021-10-14 2021-10-13 B Purchase
2.5
Green Geoff

CEO

Officer
1,000 +0.7%
3.81
US$3,810 		1,000 +0.7% 3.81 US$3,810
2021-10-13 2021-10-13 B Purchase
3.2
Soffer Rock
Non-Executive Director
12,000 +30.2%
3.76
US$45,120 		12,000 +30.2% 3.76 US$45,120
2021-10-14 2021-10-12 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
2,500 +0.0%
3.69
US$9,225 		2,500 +0.0% 3.69 US$9,225
2021-10-13 2021-10-12 B Purchase
3.2
Soffer Rock
Non-Executive Director
4,000 +11.2%
3.57
US$14,280 		4,000 +11.2% 3.57 US$14,280
2021-10-13 2021-10-11 B Purchase
3.2
Soffer Rock
Non-Executive Director
3,900 +12.2%
3.45
US$13,455 		3,900 +12.2% 3.45 US$13,455
2021-10-12 2021-10-08 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
3,015 +0.0%
3.39
US$10,221 		3,015 +0.0% 3.39 US$10,221
2021-10-12 2021-10-07 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
1,985 +0.0%
3.38
US$6,709 		1,985 +0.0% 3.38 US$6,709
2021-10-12 2021-10-07 B Purchase
3.3
Lehr Paul T

General Counsel, Secretary

Officer
1,750 +1.5%
3.34
US$5,845 		1,750 +1.5% 3.34 US$5,845
2021-10-12 2021-10-07 B Purchase
3.6
Clavijo James

CFO and Treasurer

Officer
5,000 +6.7%
3.34
US$16,700 		5,000 +6.7% 3.34 US$16,700
2021-02-26 2021-02-12 B Purchase
0.5
Soffer Donald M
Non-Executive Director
100,000 +186.9%
10.00
US$1,000,000 		100,000 +186.9% 10.00 US$1,000,000
2021-02-26 2021-02-12 B Purchase
3.2
Soffer Rock
Non-Executive Director
100 +0.4%
8.05
US$805 		100 +0.4% 8.05 US$805
2021-02-17 2021-02-12 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director
1,000 +0.0%
8.23
US$8,230 		1,000 +0.0% 8.23 US$8,230
2021-02-17 2021-02-12 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director
102,000 +1.3%
10.00
US$1,020,000 		102,000 +1.3% 10.00 US$1,020,000
Explore more

More insider trading research around Longeveron Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America